Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-19-006182

Chief Executive Officer gave up 748 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2019-03-01 Shares withheld for taxes −748 $39.97 $29,898 166,542 D
Loading xslF345X03/doc4.xml…